Global leader in pain treatments relies on ³Ô¹Ï±¬ÁÏ RIM to simplify regulatory processes, drive standardization, foster collaboration, and accelerate delivery of medicines to patients<\/i><\/p>\n
BARCELONA, Spain \u2014 25 June 2025 \u2014<\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced that Gr\u00fcnenthal is advancing its global regulatory organization with ³Ô¹Ï±¬ÁÏ RIM<\/a>. By streamlining regulatory information management (RIM) on a single, cloud-based platform, Gr\u00fcnenthal can respond faster to changing regulations and increase process efficiency, from submission planning to health authority submissions to tracking of approvals and decisions.\n<\/p>\n \n\u201cWith ³Ô¹Ï±¬ÁÏ RIM, Gr\u00fcnenthal is transforming and simplifying its global regulatory processes, improving data oversight and visibility, and enabling greater collaboration across the organization to ultimately bring safe and effective medicines to patients” said Argha Nag, vice president and head of RIM and R&D digital transformation at Gr\u00fcnenthal. “This unified approach will eliminate data silos, improve workflow efficiency, and empower our teams to focus on more strategic activities.”\n<\/p>\n \nGr\u00fcnenthal is a leader in pain management focused on addressing unmet medical needs worldwide. With ³Ô¹Ï±¬ÁÏ RIM, the company gains stronger alignment across global regulatory teams, improved data oversight, and the flexibility to scale. By bringing all cross-functional regulatory processes and information together in one application, teams can efficiently respond to regulatory needs and ensure ongoing compliance globally.\n<\/p>\n \n“³Ô¹Ï±¬ÁÏ RIM provides Gr\u00fcnenthal with the unified data and workflow platform they need to gain deeper insights into their regulatory processes,” said Paul Attridge, vice president, RIM at ³Ô¹Ï±¬ÁÏ. “This enhanced visibility and control will enable them to make faster, more informed decisions to accelerate the delivery of vital pain treatments to patients.”\n<\/p>\n \n³Ô¹Ï±¬ÁÏ RIM is part of ³Ô¹Ï±¬ÁÏ Development Cloud<\/a>, the technology foundation for product development, bringing together clinical, quality, regulatory, and safety applications to simplify end-to-end business processes and deliver process excellence.\n<\/p>\n Additional Information<\/strong> About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-looking Statements<\/strong> ###<\/p>\n
\nFor more on ³Ô¹Ï±¬ÁÏ RIM, visit: veeva.com\/eu\/³Ô¹Ï±¬ÁÏRIM<\/a>
\nConnect with ³Ô¹Ï±¬ÁÏ on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>\n<\/p>\n
\n³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.\n<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 32 and 33), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n